Practical Information about Veterinary Drugs
U.S. Food and Drug Administration Center for Veterinary Medicine (CVM)
The Center for Veterinary Medicine is the branch of the Food and Drug Administration that regulates animal drugs. CVM protects public and animal health by approving safe and effective animal drugs. We also monitor approved animal drugs once they're out on the market to make sure that they continue to be safe and effective.
Because they are a useful tool for linking dose to drug exposure, CVM uses pharmacological data during various stages of the drug approval process. For instance, CVM uses the data when evaluating a drug sponsor's dose selection and proposed study designs, when reviewing clinical study data, and even during development of product labeling.
Pharmacological data help CVM understand a drug molecule's potential characteristics, its formulation effects, and potential clinical uses. Ultimately, the data improve user instructions on product labels and provide information that will help clinicians in predicting their patient's drug response.
CVM created the following presentations to provide you with valuable information you will need in private practice and to provide answers to questions that commonly arise in companion animal practice. The following presentations provide important information about companion animal drug labels, how to report an Adverse Drug Experience (ADE), and the safe use of non-steroidal anti-inflammatory drugs (NSAIDs).
We hope you find these presentations useful. If you need additional veterinary drug-related information, please visit our website for more information: http://www.fda.gov/AnimalVeterinary. You may also contact us by email at: CVMHomeP@cvm.fda.gov or by phone at: (240) 276-9300.
A Practical Guide to Companion Animal Drug Labeling Powerpoint Presentation
This presentation is designed to help students appreciate the importance of drug labeling, how labels are developed, and the role CVM plays in developing drug labels. Drug labeling is created from the information the CVM reviews during the drug approval process. The labeling information is not randomly chosen, rather, it is critical information veterinary practitioners need in order to prescribe the drug appropriately. Case examples are included throughout the presentation to give students real-world examples of the necessity of drug label use in daily practice.
FDA/CVM Adverse Drug Experience (ADE) Reporting System Powerpoint Presentation
This presentation is designed to teach students about CVM's drug experience (ADE) reporting system. When a veterinarian or consumer contacts a drug company or CVM to report an ADE for an FDA-approved veterinary drug, what happens to that information? This presentation describes what ADEs are, why veterinarians should report ADEs, what CVM does with the data from ADE reports, how CVM creates a score for each report, how CVM notifies veterinarians of problems with approved veterinary drugs, where consumers can find ADE reports online, and how CVM is modernizing its ADE reporting system.
Canine NSAIDS and Client Education: An FDA Perspective Powerpoint Presentation
This presentation teaches students about one of the most commonly-prescribed classes of drugs in companion animal veterinary medicine: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Veterinary NSAIDs are approved for the control of pain and inflammation associated with osteoarthritis in dogs, and some are also approved for the control of postoperative pain in dogs. All human and veterinary drugs, including NSAIDs, carry risks and benefits. Because some side effects associated with NSAID use in dogs may be serious and life-threatening, the veterinarian, veterinary technician, and pet owner should know what NSAIDs are, how they work, and the possible side effects.